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ABSTRACT
Despite the personal and cultural importance of childbearing in India, limited information
exists on the extent of childbearing desires and intentions among HIV-infected
individuals in this setting. The purpose of this study was to measure the extent of
childbearing desires among HIV-infected individuals in Chennai, India, thereby testing
the hypothesis that HIV significantly influences the desire to have children. Three
hundred HIV-infected individuals were interviewed about childbearing desires and
intentions during routine visits for HIV care at an HIV specialty care clinic in Chennai,
South India. Sixteen percent of participants expressed desire for childbearing, and 9%
expressed intention to have children in the future. Desire for children was associated
with childlessness (OR 7.38, 95% CI 3.18-17.15), longer time since diagnosis with HIV
(OR 2.187, 95% CI 1.511-5.511), and absence of financial concerns about bearing
children (OR 3.81, 95% CI 1.77-8.21). Childbearing desires decreased with increasing
age (OR 0.922, 95% CI 0.87-0.98). Childbearing desires were not associated with
measures of disease progression. The most frequently cited concerns about childbearing
among participants were the potential of infecting the infant (71%) followed by the
burden of the participant’s own illness (49%). Thirty-five percent of participants
reported lack of knowledge about reducing transmission of HIV for couples trying to
conceive. Although 84% of the cohort expressed no desire for childbearing, nearly half
(48%) of those without desire stated that in the absence of HIV infection they would
desire and or intend to have children. When compared with individuals who desired
children regardless of HIV infection, these individuals were more inclined to have at least
one child already, resided in the state of Andhra Pradesh, had known their diagnosis for a

shorter time, and had more childbearing concerns related to HIV infection. Although the
prevalence of childbearing desire and intent are lower among this population than in
HIV-infected populations studied in other settings, it is likely that childbearing among
HIV-infected individuals in India will become increasingly important as HIV-infected
patients live longer and healthier lives through increasing access Highly Active
Antiretroviral Therapy (HAART) in India.
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INTRODUCTION
According to UNAIDS there are an estimated 2.5 million people, or 0.36% of the
general population, living with HIV in India, with the majority of known cases in males.
In the southeastern state of Tamil Nadu the prevalence is estimated to be as high as
0.65% among women presenting to antenatal clinics. More than 80% of reported AIDS
cases are due to heterosexual transmission (1). One retrospective study demonstrated
that marriage, monogamy, and heterosexual intercourse were the only identifiable risk
factors among HIV-infected women presenting to an HIV tertiary care center in south
India, illustrating that for many, HIV-infection occurs within the context of marriage (2).
Individuals infected with HIV in the context of marriage, as well as unmarried
individuals considering marriage, face decisions about reproduction since bearing and
raising children are integral to married life in India.
Broadly speaking, the interplay of complex biological, psychological, and social
factors—including personality, value systems, beliefs about pregnancy, birth and
parenthood, influence of spouse, parents and community, major life events, social
support, and barriers or facilitators—all inform the decision and motivation to bear
children for any individual (3). HIV infection adds layers of complexity to decisionmaking around childbearing, and its influence on these desires and intentions differ
depending on the personal, social, and biomedical context (4). For example, in one
scenario family members or one’s partner might pressure an HIV-infected individual to
have children because of cultural norms, or in an alternative scenario they might
discourage childbearing because of disapproval associated with HIV infection (5).
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In India, where the number of children per couple in 2005 was 2.9,the cultural and
societal pressure to bear children is widespread and pervasive (6). Little social science
research has explored the direct consequences of being childless in India. However, it is
broadly known that a woman’s place and security in her husband’s family depends upon
her ability to produce offspring. Failure to conceive or successfully bear children is
commonly blamed on the wife, and can lead to divorce, abandonment and abuse (7).
Studies examining factors associated with domestic violence have demonstrated that
childlessness is associated with significantly higher risk of recent domestic violence (8).
In this cultural context, the expectation that women will bear children is so
profoundly culturally embedded that the stigma and psychological burden associated with
failure to do so may be greater for some than the burden associated with HIV. Pregnancy
requires unprotected sexual intercourse, which in the case of discordant couples—couples
where one partner is infected with HIV and the other is not—means risking transmission
from one partner to the other (9). Pregnancy, childbirth and breast-feeding all involve
risk of vertical transmission from mother to infant. In addition to the risk of
transmission, living with HIV places additional health, social and financial burdens on
both parents and children. Despite these risks, many HIV-infected individuals continue
to have children, and those who do not may still be grappling with the decision and its
consequences.
Much emphasis in resource-limited settings has been placed on limiting
unplanned pregnancies, particularly in the context of HIV, given the risks of vertical and
horizontal transmission of the virus (4, 10). In some settings, HIV-infected individuals
report that they have not discussed reproduction with healthcare providers because of
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perceived negative reactions (5). However, if policy and counseling efforts focus solely
on discouragement of reproduction while ignoring the complexity of peoples’ true desires
and intentions or education, they may actually fuel sexual and mother to child
transmission of HIV rather than addressing the factors that inform these decisions (9).
Understanding how HIV-infected individuals reconcile their illness with the desire to
bear children is essential in counseling appropriately about reducing risks of transmission
and addressing individuals’ family planning needs and reproductive desires.
Historically, before the advent of Highly Active Antiretroviral Therapy (HAART)
when risk of mother to child transmission was high, pregnancy was strongly discouraged
among HIV-infected individuals in high-income settings, such as the United States (11).
In 1985, the CDC advised against pregnancy for HIV-infected women citing poor
prognosis, possible complications and risk of vertical transmission (12, 13). These
recommendations were echoed by the American College of Obstetrics and Gynecology,
which also advised against pregnancy for HIV-infected women in 1987 (14, 15).
However, the advent of HAART, which dramatically increased quality of life and
longevity and significantly reduced rates of mother to child transmission, in conjunction
with assisted reproductive options, caused shifts in policy and recommendations in highincome settings (12). In 1994 the 076 trial of the Pediatric AIDS Clinical Trial Group
(PACTG) demonstrated that treatment with zidovudine (AZT) reduced the rate of mother
to child transmission to 8% among those treated compared with a 25% transmission rate
in the untreated group (16). Administration of AZT and scheduled cesarean section
before rupture of membranes, in conjunction with avoidance of breastfeeding, was found
to further reduce mother to child transmission to 2% (17, 18). Suppression of HIV RNA
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viral load to less than 1000 copies/mL through administration of HAART can also reduce
vertical transmission to 1% to 2% regardless of mode of delivery (18). Consequently in
2001, the CDC changed its recommendations, no longer advising against pregnancy
among HIV-infected women, but rather stating that HIV-infected pregnant women should
receive counseling and information about reproductive options. Current guidelines by the
Public Health Service Task Force at the CDC provide detailed recommendations for
preconceptual and prenatal counseling, about use of antiretrovirals during pregnancy and
use of elective cesarian section so that women can make informed decisions (19). ACOG
also revised recommendations indicating that HIV-infected individuals should have the
same access to assisted reproductive technologies as their uninfected counterparts. (12)
Research from high-income settings exploring childbearing desires, intentions,
and decision-making has demonstrated that HIV-infected individuals desire children (20,
21, 22, 23, 15, 24). Even before HAART for prevention of mother to child transmission
(PMTCT), HIV-infected individuals continued to desire and bear children despite the
high risk of transmission and recommendations against pregnancy and childbearing (25).
A later study examining fertility desires and intentions among a nationally representative
sample of HIV-infected men and women receiving treatment in the U.S. demonstrated
that 28-29% of them desired children, which was lower than the proportion of women in
the US who desire children. Of those desiring children, 31-41% expected or intended to
have them in the future. In this study, younger individuals with fewer children who
reported higher overall health status were more likely to desire children as were women
whose partner’s HIV status was unknown. However, childbearing desires were not
related to disease progression. (20)
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Access to HAART allows individuals infected with HIV to live longer with
improved quality of life and decreases risk of mother to child transmission of HIV, which
influences reproductive decision-making in resource plentiful settings. A U.S. study
suggested that implementation of the Pediatric AIDS Clinical Trial Group Protocol 076
resulted in fewer HIV-infected women choosing postpartum sterilization and maintaining
options for future fertility (26). These results imply that in addition to increased longevity
for those living with HIV, the reduced risks of vertical transmission may influence
reproductive decision-making. A more recent study finding that the HAART-era birth
rate among HIV-infected women was 150% higher than the pre-HAART era birthrate as
opposed to 5% higher in uninfected counterparts, provides further compelling evidence
that HAART has had a profound impact on child-bearing in this setting (24). This study,
however, did not specify whether the increased birth rate was due to increased decisions
to bear children or a result of improved health and consequent increased fertility.
In addition to administration of HAART for PMTCT, other assisted reproductive
technologies exist, which are limited to high-income settings because of high costs (15).
Among sero-discordant couples, in addition to the risk mother to child transmission, there
is risk of horizontal transmission—from the HIV-infected partner to the uninfected
partner. Even among sero-concordant couples, meaning couples where both partners are
HIV-infected, unprotected sexual contact introduces the risk of transmission of drugresistant strains of the virus from one partner to the other (27). Studies have shown that
consistent use of condoms among sero-discordant couples, where the male partner is
infected and the female partner uninfected is 69%-94% effective at preventing
transmission (28, 29). Obviously, however, for couples that wish to conceive, condoms
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also prevent the desired pregnancy. In such couples, assisted reproductive technologies,
which reduce risk of transmission without preventing pregnancy, are available. Sperm
washing isolates spermatazoal cells from nonspermatazoal and seminal cells, which are
the reservoirs for HIV (30, 31). A retrospective multi-center study examining the safety
and efficacy of sperm washing in 1036 HIV-1 sero-discordant couples in Europe
demonstrated that sperm washing significantly reduced the risk of transmission to the
female partner (32). Another perhaps less expensive, but riskier option for serodiscordant couples wishing to conceive involves suppressing the male partner’s viral load
through antiretroviral treatment and then limiting unprotected sexual contact to the most
fertile period of the female partner’s menstrual cycle. HIV sero-concordant couples can
also use this method of timed intercourse to reduce risk of transmission of drug resistant
virus. (28) However, the technique requires education and financial and technological
resources to monitor viral load and ovulation. In sero-discordant couples where the
female partner is infected, the obvious choice is artificial insemination, where women can
inseminate themselves at very low costs, as opposed to in vitro fertilization, which is a
more costly option (33). The success of minimizing risk of transmission under these
circumstances would then be contingent upon access to PMTCT. These techniques,
while innovative and viable options in resource-plentiful settings are expensive and
largely unavailable in resource-limited settings, where basic access to PMTCT is still
limited.
As access to HAART improves in resource-limited settings, it is possible that it
will influence reproductive decision-making in these settings, given its profound impact
on childbearing among HIV infected individuals in high-income settings (24). Access to
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HAART in India has increased significantly over the past seven years. According to
UNAIDS/WHO, 785,000 of the 5.7 million people living with HIV in India need
antiretroviral therapy. Generic antiretroviral therapy became available in India in the
year 2000, which meant that first-line therapy was then available for US $1 per day. Cost
of first-line combination therapy of stavudine, lamivudine and nevirapine has further
declined to US $146 per person per year (34). The government of India has committed to
providing ART free of cost at government ART Centers (127 of them as of June 2007) as
part of its National AIDS Control Program (35). By December 2005, 60,000 people
requiring ART were receiving it, 24,000 receiving it free through the government
program, another 10,000 receiving it free through intersectoral partners, and 10,00020,000 were receiving it from other sources (34).
A study investigating the impact of the introduction of generic HAART at the
large HIV clinic where this study was conducted found a dramatic increase in the number
of people seeking treatment for HIV between 1996 and 2003 and a 20% increase in the
number of people who could afford therapy after the introduction of generics in the year
2000, most probably because patients are more likely to seek care if they believe that they
will have access to affordable therapy (36). After the year 2000 and availability of
generic HAART, Kumarasamy et al also observed a dramatic change in the natural
history of the disease at this center. The number of individuals seeking treatment for
infections decreased by 20-fold, and the death rate decreased from 25 to 5 per 100 person
years between 1997 and 2003 (36).
In resource-limited settings, risk of mother to child transmission is estimated to be
15%-25% among non-breastfeeding infants of HIV-infected mothers and 25%-45%
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among breastfeeding infants (11). PMTCT programs are available in resource-limited
settings including India. A review of national programs in 71 countries for 2004-2005
indicated that PMTCT increased from 7% in 2004 to 11% in 2005, with 8% of infants
born to HIV-infected mothers receiving antiretroviral prophylaxis (37). However, in
2006 less than 10% of estimated HIV-infected women actually received antiretrovirals
for PMTCT worldwide (38).
The World Health Organization (WHO) 2006 guidelines for PMTCT in resourcelimited settings outline an approach, which maximizes benefits and minimizes costs
through simplified, standardized regimens. These guidelines can be adapted based on the
context of the patient and resources available (38, 39). The guidelines describe a tiered
approach, which includes a triple drug regimen for women who require HAART for their
own health. Women who do not yet need HAART for their own health should take a
short course regimen, which includes nevirapine. Infants should receive nevirapine and
zidovudine. Although less effective, a nevirapine single dose regimen is recommended
where other regimens are not currently feasible. Appropriate intervention among
breastfeeding populations is unclear and still under investigation. (38, 39)
As access to HAART improves in India and other resource-limited settings,
allowing HIV-infected individuals live longer, healthier lives and reducing rates of
mother to child transmission, it is important to assess the extent of fertility desires and
intentions and the implications for vertical and heterosexual transmission in these
settings. Several studies in resource-limited settings have explored reproductive desires,
intentions, and decision-making among HIV-infected individuals and shown that HIVinfected individuals continue to desire and bear children in these contexts (40, 41, 42, 43,

9
44). One study addressing reproductive decision-making among HIV-infected individuals
in Nigeria, found that the reproductive intentions and desires in the region were high.
Sixty-three percent of HIV-infected individuals surveyed desired children, and of those
desiring children, 71.5%-93.8% intended to have children in the future (44). Another
study in Uganda found that 18% of individuals infected with HIV who were surveyed
desired more children, with many more than that, 33%, practicing unprotected sex and
thus risking pregnancy. In this study men were four times more likely to desire children
than women. PMTCT knowledge was high and did not correlate with desire for children,
however knowledge did correlate with less unprotected sex and thus less risk of
pregnancy (42). A Brazilian study surveying HIV-infected women found that 45%
desired children in the future (41). A qualitative study in Capetown, South Africa
exploring reproductive decision-making among HIV-infected individuals suggested that
fear of transmission, financial concerns, family pressure, disclosure, and community
attitudes influence individuals’ childbearing decisions (40). To our knowledge no such
study examining the reproductive desires and intentions among HIV-infected individuals
has previously been conducted in India, where the HIV epidemic and the cultural context
affect women uniquely.
The primary aim of this study was to assess the extent of reproductive desires and
intentions in HIV-infected individuals in an HIV care center in South India, and to
examine socio-demographic and health-related factors associated with the desire and
intention to bear children in this population. A secondary aim was to assess HIVinfected individuals’ knowledge about reproductive options that would reduce the risks of
transmission of HIV.
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METHODS
Study Site
This study was conducted at Y.R. Gaitonde Center for AIDS Research and
Education (YRG CARE), a non-governmental HIV specialty care center located in
Chennai, in the state of Tamil Nadu, South India. Since its inception in 1996, more than
10,000 patients infected with HIV have been in care at the center, with approximately
2000-3000 patients currently receiving ongoing care. YRG CARE provides
comprehensive services, including voluntary counseling and testing services,
psychosocial counseling, inpatient and outpatient treatment facilities, laboratory
monitoring, as well as nutritional support for people living with and affected by HIV.

Data Collection
A semi-structured questionnaire, consisting of 18-23 questions pertaining to the
participant’s reproductive history, contraceptive practices, reproductive desires and
intentions, and knowledge about reproductive options for reduction of horizontal and
vertical transmission, was administered in a face-to-face interview in the language best
understood by the participant, either Tamil or Telegu. The questionnaires were translated
from English to Tamil and Telegu and then back-translated to English for verification
prior to the commencement of data collection. The answers to open-ended questions
about the reasons for desiring children and concerns about bearing children were coded
by the interviewer according to categories established from a review of relevant literature
about childbearing decision-making among HIV-infected individuals in other settings.
General demographic, medical and socio-economic information was obtained from the
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patient’s clinic record. The most recent CD4 count and the lowest CD4 count were
obtained from a review of each patient’s medical record. A history of opportunistic
infections and prior hospitalizations was obtained from the YRG CARE HIV
Observational Database (45).
This study was approved by the institutional review board at YRG CARE and by
the Yale Human Investigations Committee.

Study Sample
The questionnaire was administered to previously diagnosed HIV-infected men
and women presenting for routine care between February and April 2007. Patients were
eligible to participate if they were female between the ages of 18-40 or male between the
ages of 21-50. Females reach age of majority in India at age 18, whereas age of majority
for males is 21. Patients were eligible if they had been in treatment at YRG CARE for a
minimum of five months, so that they would have had time to develop relationships with
their care providers. Patients were eligible if they were either HAART naïve or had
undergone no changes in their HAART regimen in the previous 3 months and had not
experienced a WHO stage IV AIDS-defining diagnosis within the previous 3 months.
These eligibility criteria were established to avoid obtaining responses that would be
unduly influenced by an acute disease-related event.
Three hundred eligible participants were recruited to participate in the study by
counselors at YRG CARE. The study was explained to participants and informed
consent was obtained in the language best understood by each participant.
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Data Analysis
All statistical analysis was performed using SPSS software (version 10.0.5,
Chicago, USA). Mean plus or minus standard deviation was used for variables which
were normally distributed, and median, interquartile range (IQR), and range, if required,
were used for variables that were influenced by extreme values.
Chi-square test and t-test were conducted on categorical and continuous variables.
Multivariate logistic regression was performed to study the relationship between the
various socio-demographic characteristics, health-related characteristics, concerns about
childbearing, and knowledge regarding methods to reduce transmission of HIV among
respondents who desired children compared to those who did not desire to have children.
A p-value of less than 0.05 was considered statistically significant.
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RESULTS
Among the 300 study participants, over one quarter were female (n=85, 28%).
The mean age of participants was 35(6) years. Most of the participants were married
(n=259, 86%), while 8% (n=23) had been previously married, and 6% (n=18) had never
been married. Over half of the participants came from the state of Tamil Nadu (n=156,
52%), followed by the state of Andhra Pradesh (n=131, 44%), just to the north of
Chennai. The remaining participants came from the neighboring southern states of
Pondicherry, Kerala and Maharashtra (n=13, 4%). Close to one-third of participants
(n=106, 35%) were sero-discordant with their primary partner, meaning that their partner
was not infected with HIV, and over half (n=168, 56%) were in sero-concordant
partnerships, meaning that their partner was known by them to be HIV-infected, while
few (n=10, 3%) had not had a partner since finding out their status or did not know the
status of their partner (n=11, 5%). Among the 265 patients who had a primary partner,
almost all (n=265, 93%) had disclosed their HIV status to their partner. Well over half of
the respondents (n=164, 55%) had two or more children, just under one-third had one
child (n=89, 30%), and less than one-sixth (n=46, 15%) of the respondents were
childless. The mean number of children among the participants was 1.3. Among the
women surveyed who had previously been pregnant, the mean age of first pregnancy was
21. Table I summarizes the general socio-demographic and health-related characteristics
of the participants.
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Table I. Characteristics of participants
Sociodemographic characteristics
Total participants
Gender
Mean Age (SD), years
Age group

Education

Occupation

State

Marital Status

Mean (SD) age of first
pregnancy among women,
years
Number of Children

Male
Female
18-24
25-30
31-40
41-50
None
Primary
Middle
Secondary
Graduate
Unknown
Unskilled
Skilled
Professional
Housewife
Truck Driver
Unemployed
Unknown
Tamil Nadu
Andhra Pradesh
Pondicherry
Karnataka
Maharashtra
Kerala
Never married
Married
Separated
Divorced
Widow/widower

0
1
2
3
4 or more

300
215(72%)
85(28%)
35(6)
13(4%)
58(19%)
183(61%)
46(20%)
32(11%)
28(9%)
65(22%)
121(40%)
46(15%)
7(2%)
52(17%)
110(37%)
26(9%)
77(26%)
24(8%)
5(2%)
6(2%)
156(52%)
131(44%)
4(1%)
6(2%)
1(0%)
2(1%)
17(6%)
261(87%)
4(1%)
5(2%)
13(4%)
21(3)
46(15%)
89(30%)
137(46%)
22(7%)
5(2%)
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Health-Related Characteristics

Total participants

300

Mean (SD) time since
diagnosis, months
Time since diagnosis

48 (30)

Median (IQR) most recent
CD4 count, cells/mL
Most recent CD4 count,
cells/mL

Median (IQR) lowest CD4
count, cells/mL
Lowest CD4 count,
cells/mL

Number of prior
hospitalizations

History of AIDS-defining
Opportunistic Infection
Currently on HAART
Mean (SD) duration on
HAART, months
Duration on HAART

Mean (SD) time in care at
YRG CARE
Time in care at YRG CARE

Disclosure to primary
partner

5 months-1 year
1 year-2 years
2 years-3 years
3 years-4 years
4 years-5 years
>5 years

27(9%)
61(20%)
42(14%)
44(15%)
27(9%)
99(33%)
370(241-538)

<50
50-199
200-499
≥500
unknown

2(1%)
44(15%)
165(55%)
88(29%)
1(0%)
161(91-281)

<50
50-199
200-499
≥500
unknown
0
1
2
≥3
Yes
No
Yes
No

47(16%)
128(43%)
97(32%)
27(9%)
1(0%)

4 months-1 year
1 year-2 years
2 years-4 years
>4 years

63 (30%)
55(26%)
59(28%)
34(16%)
40(27)

5 months-1 year
1 year-2 years
2 years-3 years
3 years-6 years
>6 years
Yes
No
No partner

44(15%)
63(21%)
57(19%)
90(30%)
46(15%)
265(88%)
14(5%)
21(7%)

214(71%)
22(7%)
34(11%)
30(10%)
99(33%)
201(67%)
211(70%)
89(30%)
26(21)
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HIV status of primary
partner
Belief in effectiveness of
HAART

Negative
Positive
Unknown
No partner
Yes
No
Do not know

106(35%)
168(56%)
9(3%)
17(6%)
284(95%)
11(4%)
5(2%)

In terms of health status, on average the patients had been aware of their diagnosis
for 4 years (mean: 48±30 months). The median (IQR) most recent CD4 count was
370(241-538), and the median (IQR) lowest CD4 count recorded 161(91-281). One-third
(n=99, 33%) of the participants had previously been diagnosed with an AIDS-defining
opportunistic infection (OI), and just under one-third (n=86, 29%) had been hospitalized
at least once during the history of their infection. Over two-thirds (70%) of the
participants were taking highly active antiretroviral treatment (HAART) at the time of the
interview, and the mean duration on HAART was 26 (SD:21) months. Ninety-five
percent of the participants believed that HAART was effective at slowing the course of
HIV infection regardless of whether or not they were taking HAART. The participants
had been receiving care at YRG CARE for a mean duration of 40 (SD:27) months.
Among the 300 HIV-infected individuals interviewed, 16%(n=47) expressed
desire to have at least one more child, whereas 9% (n=28), or 60% of those who desired a
child, expressed the intention to actually bear more children. So few participants
expressed intention for childbearing that we were unable to compare them to those who
did not intend to have children.
Eighty-one percent of people surveyed were greater than 30 years of age, which
suggests that older individuals may have been over-represented in this cohort. However a
separate analysis was done among individuals less than age 35, which showed that the
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prevalence of childbearing desires among the younger group was similar, 19% as
opposed to 16% in the entire cohort, and the associated factors among the younger
participants were similar as well.
Table II shows the percentage distribution of the study participants and the mean
values by selected characteristics according to the desire for children. Of those who
desired children 74% were male and 26% were female which is similar to the sex
distribution among those who did not desire children. Men and women who desired
children were younger than those who did not desire children (mean (SD) age 32(6) and
35(6) respectively, p=0.005) and were more likely to have never married than those who
did not desire to have a child (17% vs 4%; p<0.001). The participants desiring children
were more likely to be childless, and childbearing desires decreased with increasing
number of children. The participants who desired children were more likely to have been
pregnant or had a partner who had been pregnant since finding out that they were HIVinfected than those who did not desire children. The participants who desired children
had been aware of their HIV diagnosis for longer time than those who did not desire
children (41 months vs. 46 months; p=0.002). However the desire for children was not
significantly related to the level of disease severity in terms of the lowest CD4 count, a
history of opportunistic infection or hospitalizations. Desire for children was not
significantly associated with whether or not the participants were taking HAART or with
the duration on HAART among those who were taking it.
The most frequently cited reason for desiring children was personal fulfillment
(32%), followed by family pressure to bear children (28%), community pressure (13%),
and a partner’s desire for a child (13%). Fewer respondents cited desire for a child of a
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specific sex as a reason for desiring another child. Few people recognized the impact of
treatment as a reason for desiring children, whether it was the impact of treatment on
their own health or treatment as a means of reducing vertical transmission. The reasons
for desiring children among participants who desired them are summarized in Table IV.
The most commonly expressed concern about childbearing was possible
transmission of HIV to the offspring, which was cited by 213 (71%) of the respondents,
regardless of whether or not they wanted to have children. That predominating concern
was followed by the burden of the respondent’s own illness. Seventy-three of the 132
participants who did not have a partner infected with HIV stated they would be concerned
about transmitting HIV to a partner in the attempt to conceive. Financial concern
associated with bearing another child was expressed significantly more often among
individuals who did not desire children (n=120, 47%) compared with those who desired
children (n=9, 19 %, p<0.001). Fifteen percent (n=7) of individuals desiring children
versus 0% (n=1) of individuals not desiring children stated that they had no concerns
about childbearing (p<0.001).
Knowledge about reproductive options for reducing risks of transmission was not
significantly associated with the desire for children. However, among the entire cohort,
35% reported no knowledge about methods of reducing vertical and horizontal
transmission while trying to conceive, illustrated in Figure 1. Fifty-four percent cited
HAART for PMTCT as a means of reducing vertical transmission, with only 31%
reporting knowledge about c-section as part of PMTCT, and 29% recognizing that
formula-feeding played a part in PMTCT.
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Table II. Percentage distribution of study participants and mean values by sociodemographic characteristics according to desire for children
Characteristic
Desire children
Do not desire children p
N(%)
Gender
Female
Male
Mean (SD) Age, years
Age group
18-24 years
25-30 years
31-40 years
41-50 years
Marital Status
Never married
Married
Separated/divorced/widowed
Has at least one child
Yes
No
Number of Children
0
1
2
≥3
Occupation
Unskilled
Skilled
Professional
Housewife
Truckdriver
Unemployed
Unknown
Education level
None
Primary
Middle
Secondary
Graduate
Unknown
State
Tamil Nadu
Andhra Pradesh
Other

47(16%)

253(84%)

12(26%)
35(74%)
32(6)

73(29%)
180(71%)
35(6)

4(9%)
13(28%)
28(60%)
2(4%)

9(4%)
45(18%)
155(61%)
44(17%)

0.643

0.005
0.033

<0.001
8(17%)
39(83%)
0(0%)

9(4%)
222(88%)
22(7%)
<0.001

22(47%)
25(53%)

231(91%)

25(53%)
20(43%)
2(1%)
0(0%)

22(8%)
69(27%)
135(53%)
27(11%)

4(9%)
21(44%)
5(11%)
10(21%)
5(11%)
1(2%)
1(2%)

48(19%)
89(35%)
21(8%)
67(26%)
19(8%)
4(2%)
5(2%)

2(4%)
5(11%)
8(17%)
21(45%)
10(21%)
1(2%)

30(12%)
23(9%)
57(23%)
100(39%)
36(14%)
6(2%)

33(70%)
13(28%)
1(2%)

123(49%)
118(47%)
12(4%)

22(47%)
<0.001

0.453

0.476

0.119
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Table III. Percentage distribution of study participants by HIV-related characteristics
according to desire for children
Characteristic
Desire children
Do not desire children p
N(%)

47(16%)

Disclosure to primary partner*
Yes
38(97%)
No
1(3%)
HIV status of primary
partner*
25(66%)
Positive
13(34%)
Negative
HIV-infected child
Yes
3(6%)
No
44(94%)
Pregnancy since HIV status
known in patients
14(36%)
Yes
25(64%)
No
*only asked of participants with a partner

253(84%)
0.449
227(95%)
13(5%)
0.764
143(61%)
93(39%)
0.946
18(7%)
235(93%)
0.004
40(16%)
205(84%)

Table III. Percentage distribution of study participants and mean values by health-related
characteristics according to desire for children
Characteristic
Desire children
Do not desire children p
N(%)

47(16%)

253(84%)

Mean (SD) duration since
diagnosis, months
Duration since diagnosis of
HIV
5 months-1 year
1 year-2 years
2 years-3 years
3 years-4 years
4 years-5 years
>5 years
Mean (SD) duration of
attendance at YRG, months
Duration of attendance at
YRG
5 months-1 year
1 year-2 years
2 years-3 years
3 years-6 years
>6 years
Median (IQR) recent CD4,
cells/mL

41(30)

46(29)

0.002
0.011

2(4%)
3(6%)
8(17%)
4(9%)
6(13%)
24(51%)
49(28)

25(10%)
58(23%)
34(13%)
40(16%)
21(8%)
75(30%)
39(27)

0.011
0.074

4(9%)
5(11%)
10(21%)
16(34%)
12(25%)
396(261-593)

40(16%)
58(23%)
47(19%)
74(29%)
34(13%)
370(240-535)

0.347
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Most recent CD4 count,
cells/mL
<50
50-199
200-499
≥500
unavailable
Median (IQR) lowest CD4,
cells/mL
Lowest CD4 count, cells/mL
<50
50-199
200-499
≥500
unavailable
History of AIDS-defining OI
Yes
No
Prior hospitalization
No
Yes
Receiving HAART
Yes
No
Mean (SD) duration on
HAART, months
Duration on HAART among
patients receiving HAART
4 months-1 year
1 year-2 years
2 years-4 years
>4 years
Belief in effectiveness of
HAART
Yes
No
Do Not Know

0.889
0(0%)
6(13%)
26(55%)
15(32%)
0(0%)

2(1%)
38(15%)
139(55%)
73(29%)
1(0%)

181(96-320)

160(82-271)

7(15%)
18(38%)
14(30%)
8(17%)
0(0%)

40(16%)
110(43%)
83(33%)
19(8%)
1(0%)

0.317
0.226

0.863
15(32%)
32(68%)

84(33%)
169(67%)

36(77%)
11(23%)

178(70%)
75(30%)

0.385

0.079
28(60%)
19(40%)
34(23)

183(72%)
70(28%)
28(21)

0.122
0.044

8(29%)
3(11%)
8(29%)
9(32%)

55(30%)
52(28%)
51(28%)
25(10%)
0.535

43(92%)
3(6%)
1(2%)

241(95%)
8(3%)
4(2%)
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Table IV. Reasons for desiring children
Number of participants desiring children
Reasons
Personal fulfillment
Family pressure
Community Pressure
Partner desires a child
Desire to have a male child
Desire to have a female child
Treatment working, patient feels healthy
Access to medications to reduce transmission
Religious reasons
Other

47(100%)
32(74%)
12(28%)
6(13%)
6(13%)
3(7%)
2(5%)
3(7%)
3(7%)
2(5%)
10(23%)

Table V. Percentage distribution of study participants and mean values by concerns and
knowledge regarding reproductive options according to desire for children
Characteristic
Desire children
Do not desire children p
N(%)
Concerns about bearing
children
Infecting infant
Burden of own illness
Infecting partner
Financial burden
No concerns
Stigma associated with illness
Family already complete
Other
Knowledge about reproductive
options
None1
ART for mother and infant
Cesarian section
Formula feeding
Adoption
Treatment with ART in
discordant couples
Sperm donation
Sperm washing
Desire for childbearing in
absence of HIV
Yes
No
Do not know
1

47(16%)

253(84%)

30(64%)
18(38%)
10(21%)
9(19%)
7(15%)
5(11%)
0(0%)
3(6%)

183(81%)
129(80%)
63(25%)
120(47%)
1(0%)
12(5%)
26(10%)
9(4%)

0.238
0.110
0.595
<0.001
<0.001
0.108
0.021

12(26%)
27(57%)
33(70%)
15(32%)
9(19%)

92(36%)
136(54%)
59(23%)
71(28%)
49(19%)

0.152
0.606
0.895
0.955
0.972

2(4%)
4(9%)
0(0%)

2(1%)
10(4%)
3(1%)

0.057
0.174
0.453

*

121(48%)
130(51%)
2(1%)

Subjects did not report known means of reducing transmission for HIV-infected couples wishing to
conceive
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Figure 1. Knowledge about reproductive options that reduce vertical and horizontal
transmission in HIV-infected couples wishing to conceive
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The results of univariate analysis, comparing those who expressed desire for
children to those who did not desire children, summarized in Table VI, demonstrate that
desire for childbearing was associated with younger age (odds ratio, 0.922; 95% CI=0.870.98), being childless (odds ratio, 7.38; 95% CI=3.18-17.15), and being unmarried (odds
ratio, 5.193; 95% CI=1.89-14.30). Increasing number of children was associated with
decreased childbearing desires (odds ratio, 0.051; 95% CI=0.012-0.221). Absence of
financial concern about having another child was also associated with desire for children
(odds ratio, 3.81; 95% CI=1.77-8.21). Greater than four years since the diagnosis of HIV
was associated with the desire for children (odds ratio, 2.187; 95% CI=1.511-5.511). In
the multivariate model, desire for children was significantly associated with being
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childless (odds ratio, 8.992; 95% CI= 4.368-19.742) and with greater time since diagnosis
(odds ratio, 3.024; 95% CI= 1.419-6.445).
Table VI. Univariate and multivariate analysis of characteristics associated with desire
for childbearing in entire cohort
Characteristic Desire
Do not desire
Univariate
Multivariate
children
children
regression
N=47
Mean (SD) age,
32(6)
years
Marital Status
38(81%)
Married
8(17%)
Never married
1(2%)
Other
Childless
Yes
25(53%)
Mean number of
1.09
children*
Time since
diagnosis
4 years or more
30(64%)
Concern about
financial burden
of another child
No
38(81%)
*among participants with children

N=253

OR

95% CI

OR

95% CI

35(6)

0.922

0.87-0.98

0.945

0.882-1.01

222(88%)
9(4%)
21(9%)

5.19
0.266

1.89-14.3
0.04-2.03

-

22(9%)

7.38

3.18-17.2

8.99

1.86

0.051

0.012-0.221

96(38%)

2.19

1.51-5.51

3.02

1.42-6.45

133(53%)

3.81

1.77-8.21

1.86

0.788-4.37

-

4.37-19.7

-

-

Although 84% of the cohort expressed no desire for childbearing, nearly half
(48%) of those without desire stated that in the absence of HIV infection they would
desire and or intend to have children. In order to assess the effect of HIV infection on the
desire for children, we compared the group who openly expressed desire for children
despite HIV infection, to those who stated that they did not currently desire children but
would desire them in the absence of HIV. These results are summarized in Tables VIIXVI. When compared with the 47 who expressed desire for children, the 121 who stated
that they would desire children in the absence of HIV were not significantly older (mean
age 32 vs. 35) and did not differ significantly according to gender. Study participants
who would have desired children in the absence of HIV infection are more likely to have
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at least one child already (87% vs 47%, p<0.0001), tended to have a shorter duration
since diagnosis and were more likely to live in the neighboring state of Andhra Pradesh
(56% vs 28%, p=0.002) compared to participants who expressed desire for children
regardless of HIV status (Table VII, Table IX). However, desire for more children in the
absence of HIV was not significantly associated with any measures of disease
progression such as most recent or lowest CD4 count, history of opportunistic infections
or history of hospitalizations (Table IX). Individuals who expressed that they would
desire children if they were HIV-negative were significantly more likely to express
concern about vertical transmission, concern about the burden of their own illness and
financial burden when compared with the participants who expressed desire for children
regardless of HIV status (Table X). Their knowledge about methods for reducing
transmission among couples wishing to conceive was not significantly different than the
participants who desired children regardless of their HIV status (Table X).
The results of univariate and multivariate analysis, comparing those who would
have desired children if they were HIV-negative to those who desired children regardless
of their HIV status are summarized in Table XVI. These results demonstrate that state of
residence, already having a child, time since diagnosis, and concern about transmission of
HIV infection to the infant were all related to the influence of HIV on reproductive
desire. Multivariate analysis demonstrates that participants who already had at least one
child (odds ratio, 5.617; 95% CI=2.174-14.515) and resided in the state Andhra Pradesh
(odds ratio, 3.560; 95% CI=0.012-0.221) were more likely to have had HIV status
significantly influence their desire for another child.
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Table VII. Percentage distribution of study participants and mean values by sociodemographic characteristics according to desire for children regardless of HIV status and
desire for children in the absence of HIV infection
Characteristic
Desire Children Would desire children p
if HIV negative
N(%)
Gender
Female
Male
Mean Age (SD)
Age
18 to 25
26 to 35
31 to 50
Marital status
Never married
Married or previously married
Education
None
Primary
Middle
Secondary/technical
Graduate
Employment
Unskilled or unemployed
Skilled
Professional
Housewife
Truck Driver
State of residence
Tamil Nadu
Andhra Pradesh
Number of children
0
1
2 or more
Has at least one child
Yes
No

47

121

12(26%)
35(74%)
32(5)

34(28%)
87(72%)
35(6)

6(13%)
28(60%
13(28%)

8(7%)
68(56%)
45(37%)

0.848
0.029
0.287

0.046
8(17%)
39(83%)

8(7%)
113(93%)

2(4%)
5(11%)
8(17%)
21(46%)
10(22%)

13(11%)
13(11%)
21(18%)
53(45%)
27(15%)

5(11%)
21(46%)
5(11%)
10(22%)
5(11%)

27(23%)
47(40%)
8(7%)
30(25%)
6(5%)

33(72%)
13(28%)

50(44%)
64(56%)

25(53%)
20(43%)
2(4%)

15(13%)
55(46%)
50(42%)

22(47%)
25(53%)

104(87%)
16(13%)

0.612

0.262

0.002
<0.0001

<0.0001
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Table VIII. Percentage distribution of study participants and mean values by HIV-related
characteristics according to desire for children regardless of HIV status and desire for
children in the absence of HIV infection
Characteristic
Desire Children Would desire children p
if HIV negative
N(%)
Disclosure of HIV status to
primary partner
Yes
No
Partner’s HIV status
Positive
Negative
Child with HIV
Yes
No
Pregnancy since diagnosis
Yes
No

47

121
0.608

38(97%)
1(3%)

106
4

25(66%)
13(34%)

65(58%)
47(42%)

8(17%)
39(83%)

7(6%)
114(94%)

14(30%)
33(70%)

26(21%)
95(79%)

0.447
0.033
0.313

Table IX. Percentage distribution of study participants and mean values by health-related
characteristics according to desire for children regardless of HIV status and desire for
children in the absence of HIV infection
Characteristic
Desire Children Would desire children p
if HIV negative
N(%)
Mean (SD) duration since
diagnosis, months
Duration since diagnosis
≤48 months
>48 months
Median (IQR) most recent CD4,
cells/mL
Most recent CD4, cells/mL
<200
≥200
Median (IQR) lowest CD4,
cells/mL
Lowest CD4 count, cells/mL
<200
≥200
History of AIDS-defining OI
Yes
No

47
57(19)

121
48(21)

17(36%)
30(64%)
396(261-593)

69(57%)
52(43%)
332(207-506)

6(13%)
41(87%)

29(24%)
91(76%)

181(96-320)

152(70-252)

25(53%)
22(47%)

76(63%)
44(37%)

15(32%)
32(68%)

35(29%)
86(71%)

0.011
0.017
0.145
0.139
0.137
0.291
0.704
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Taking HAART
Yes
No
Mean (SD) time on HAART,
months
Belief in effectiveness of
HAART
Yes
No

0.123
28(60%)
19(40%)

87(72%)
34(28%)

34(23)

29(22)

0.239
0.468

43(9%)
4(91%)

115(95%)
6(5%)

Table X. Percentage distribution of study participants and mean values by concerns and
knowledge according to desire for children regardless of HIV status and desire for
children in the absence of HIV infection
Characteristic
Desire Children Would desire children p
if HIV negative
N(%)
Concerns about bearing
children
Infecting the partner
Infecting infant
Burden of own illness
Financial burden
Stigma
Family complete
No concerns
Knowledge about reproductive
options
Adoption
Formula feeding
ART for discordants
Sperm donation
Sperm washing
ART for PMTCT
C-section
none

47

121

10(21%)
30(64%)
18(38%)
9(19%)
5(11%)
0(0%)
7(15%)

40(33%)
98(81%)
74(61%)
48(40%)
10(8%)
0(0%)
1(1%)

0.134
0.019
0.008
0.012
0.628
0.001

9(19%)
13(28%)
2(4%)
4(9%)
0(0%)
27(57%)
11(23%)
12(26%)

31(26%)
53(44%)
2(2%)
1(1%)
1(1%)
80(66%)
42(35%)
31(26%)

0.377
0.054
0.312
0.022
1.0
0.372
0.196
0.991
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Table XI. Univariate and multivariate analysis of characteristics associated with desire
for childbearing in the absence of HIV infection
Characteristic Desire
Would desire
Univariate
Multivariate
children
children if
regression
HIV-negative
N=47
Mean age, years
Marital Status
Never married
Currently or
previously
married
State
Andhra Pradesh
Tamil Nadu
Have at least
one child
Yes
Time since
diagnosis
4 years or more
Concern about
infecting infant
Concern about
burden of own
illness
Concern about
financial burden
of another child
No concerns
about bearing
another child

N=121

OR
1.07

95% CI
1.01-1.14

OR
1.06

95% CI
0.974-1.14

113(93%)

2.90

1.02-8.24

0.402

0.014-11.5

13(28%)
33(72%)

64(56%)
50(44%)

3.25

1.55-6.82

3.57

1.40-9.10

22(47%)

105(87%)

5.62

2.17-14.5

4.24

1.36-13.28

30(64%)

52(43%)

0.765

0.619-0.945

0.459

0.191-1.10

30(64%)

98(81%)

0.414

0.196-0.875

0.489

0.175-1.37

18(38%)

74(61%)

0.394

0.197-0.788

0.479

0.203-1.13

9(19%)

48(40%)

0.360

0.160-0.812

0.786

0.293-2.11

7(15%)

1(1%)

21.0

2.51-176
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35

8(17%)

8(7%)

39(83%)

-

-
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DISCUSSION
Sixteen percent of HIV-infected individuals expressed desire for children in this
sample of mostly married, male subjects, who for the most part already had at least one
child, were diagnosed a mean of 4 years prior to the survey, and who had
overwhelmingly disclosed their HIV status to their primary partner. Despite pervasive
cultural pressure to bear children, desire for children in this setting was less extensive
than had been reported among HIV-infected individual in high-income countries (2545%) and in other resource-limited settings in Africa (18%-63%) (20, 23, 41, 42, 44).
Those who desired children in this context tended to be younger, unmarried, and had no
children or fewer children than those who did not desire more children. Neither
biological markers of disease progression nor exposure to HAART significantly impacted
the desire for children. However, HIV infection did play a significant role in the desire
and the decision to bear children; nearly half of participants who did not express desire
for children said that in the absence of HIV infection they would want more children.
In this sample younger age is positively associated with desire for children, which
is consistent with similar studies in a wide range of settings (20, 23, 41, 42, 44). Being
childless was the strongest predictor of childbearing desire in this cohort, which was also
consistent with findings in resource-limited settings in Nigeria and Uganda (21, 44). This
may also explain why being unmarried was associated with desire for children, since
individuals who were unmarried did not yet have any children. Individuals without
children were almost six times more likely to desire children than individuals with one or
more children. Likewise, individuals with one child were more inclined to desire another
child compared with individuals who already had two or more. These findings support
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the possibility that concerns and stigma associated with being childless in this personal
and socio-cultural context may outweigh people’s concerns about transmission, finances,
and the burden of their illness.
A similar study conducted in Nigeria, where desire for children was far more
prevalent, noted that desire for childbearing was associated with nondisclosure (44). In
our cohort, the overwhelming majority of patients had disclosed at least to his or her
primary partner, which may have been protective. In addition to indicating a certain level
of personal acceptance of HIV infection, disclosure may discourage people from bearing
children because of stigma; once an individual’s HIV-status is disclosed, his or her family
or community may be concerned about transmission to the child and discourage the
individual from having children. However, since respondents in our cohort had
overwhelmingly disclosed their HIV status to their primary partner, we are unable to
comment on any association between non-disclosure and desire or intention for
childbearing in this setting.
Childbearing desires appeared to be independent of health-related factors, such as
most recent CD4 count, lowest CD4 count, or history of opportunistic infections, which is
consistent with the Nigerian and Ugandan studies. However, the finding that individuals
with longer time since diagnosis have greater desire for children may suggest that those
desiring children are more inclined to view HIV as a chronic disease rather than an
imminently life-threatening illness. Although childbearing desires were not influenced by
treatment with HAART, the significant association between the desire to bear children
and longer duration since diagnosis, suggests that childbearing desires, and perhaps
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intentions, may become increasingly prevalent as longevity improves through better
access to treatment and specialized care.
Other studies have suggested that improved availability of HAART, which allows
people to live longer, healthier lives and reduces risks of mother to child transmission,
has increased childbearing desires and intentions in settings like the U.S. and South
Africa (24, 26, 40). In our cohort, childbearing desires were not significantly associated
with whether or not a patient was taking HAART or by the duration of treatment with
HAART, which may appear to contradict findings that access to HAART increases
childbearing among HIV-infected couples. Our finding might be explained by several
factors. Nearly all patients interviewed believed in the effectiveness of HAART at
slowing the progression of HIV regardless of their childbearing desires or intentions.
Furthermore all participants who needed HAART had access to it (although this was not
true of all patients with HIV in India), which means that there was no comparison group
of individuals who did not have access to HAART in this study. Since all participants
believed in the effectiveness of HAART we are unable to comment on any association
between participants’ belief in the effectiveness of treatment and their desire for
additional children.
Despite access to treatment among this study population and their nearly universal
belief in the effectiveness of HAART at slowing infection, 46% of respondents did not
identify HAART as a means for preventing mother to child transmission. This finding
suggests that although patients understood the role of HAART in slowing the progression
of their own disease, the majority of them did not fully understand the role of HAART in
preventing vertical transmission. This finding might explain why the percentage that
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expressed desire was relatively low (16%), similar to a study conducted in Uganda where
the population surveyed did not have access to HAART and only 18% expressed desire
for children (42). This seeming lack of knowledge, particularly among the individuals
desiring children, is surprising in this context of specialized care and ongoing counseling
and argues for increased widespread efforts in education and dissemination of
information about prevention of vertical transmission of HIV.
Childbearing decisions in India, as elsewhere, are influenced by culture, religion,
family structure, and perception of identity (46). This study did not thoroughly
qualitatively explore individuals’ complex reasons for desiring children, nor their
concerns about bearing them. Eighty-four percent of the cohort expressed no desire for
childbearing. However, nearly half of those without desire stated that in the absence of
HIV infection they would desire and or intend to have children which suggests that being
infected with HIV has a powerful influence on the decision of whether or not to bear
children. A comparison of the participants who would desire children in the absence of
HIV to the group who desired children despite their HIV infection begins to illustrate the
impact of HIV on the decision-making. The participants who would have desired more
children in the absence or HIV generally already had at least one child, and thus were
potentially less susceptible to the cultural stigma or personal sense of loss from being
childless. They also tended to live in Andhra Pradesh, which suggests that individuals
living in Tamil Nadu, in closer proximity to specialized HIV care, may be more willing
to consider childbearing in the face of HIV infection. The participants who would have
desired more children in the absence of HIV also more commonly expressed concern
about infecting the infant, concern over the financial burden (which may include the
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current costs of HAART or the anticipated costs of eventual treatment), and the burden of
illness as reasons for not bearing children than the participants who wanted children
regardless of their HIV status. This finding suggests that for the majority of individuals
who would want children, concerns about the risks of childbearing in the context of HIV
outweigh their desire or the personal and cultural importance of bearing more children.
Since this study was conducted in a non-governmental specialized HIV care
setting, and the study subjects were mostly male, married, had at least one child and had
disclosed their HIV status to their primary partner, these findings may not be
generalizable to the entire population of HIV-infected individuals in India. The
limitations of this study also include the potential of inter-interviewer inconsistency, as
well as the format of face-to-face administration of the questionnaire as opposed to
anonymous administration. The reason for face-to-face interviews was the importance of
including all participants regardless of whether or not they were literate, as well as the
ability of counselors to address questions or concerns that arose after administration of
the questionnaire. However, participants may have been hesitant to disclose their true
desires and intentions in this setting. Another limitation was that this study did not
address the influence of quality of life on the decision of whether or not to bear children,
which has been shown to influence reproductive decision-making in other studies. This
meant that although we were able to use markers such as CD4 count and history of
opportunistic infection as indicators of disease progression, we were not able to account
for a patient’s more subjective understanding or experience of these factors and its
relationship to their childbearing desires.
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Future directions of research should include attitudes of health care professionals
and policy makers about reproductive decisions among HIV-infected individuals. An
exploration of pregnancy risk behavior in this population in light of the stated desires and
intentions would also be illuminating as would a comparison to the childbearing desires,
intentions and decision-making among an HIV-infected cohort compared to uninfected
controls.
In conclusion, this study, which is the first to explore the childbearing desires
among HIV-infected individuals in India, illustrates that as people live longer with HIV,
they are inclined to consider childbearing. Although HIV influences people’s decisions
about childbearing, in terms of the potential for infecting the infant, the burden of illness
and financial burdens, it is likely that as access to HAART continues to improve,
individuals with HIV will live longer lives, and childbearing will become a more pressing
concern in this context, particularly among HIV-infected individuals who do not yet have
children. It is important that HIV-infected individuals who are considering childbearing
have the opportunities to discuss the risks and options, particularly the benefit and
importance of HAART for PMTCT, with health-care providers.
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